EMEA-000412-PIP01-08-M01
Key facts
Invented name |
Levemir
|
Active substance |
Insulin detemir
|
Therapeutic area |
Endocrinology-Gynaecology-Fertility-Metabolism
|
Decision number |
P/0172/2014
|
PIP number |
EMEA-000412-PIP01-08-M01
|
Pharmaceutical form(s) |
Solution for injection
|
Condition(s) / indication(s) |
|
Route(s) of administration |
Subcutaneous use
|
Contact for public enquiries |
Novo Nordisk A/S
|
Decision type |
PM: decision on the application for modification of an agreed PIP
|
Compliance procedure number |
EMEA-000412-PIP01-08-M01
|
Compliance opinion date |
14/11/2014
|
Compliance outcome |
positive
|